Earnings Play: HCA Healthcare
Jason Lubin October 23, 2020 4:15 PM
Look for a breakout from the symmetrical triangle pattern.
On Monday, before market, HCA Healthcare (HCA) is anticipated to report third quarter EPS of $2.28 compared to $2.23 a year ago on revenue of approximately $13.0 billion vs. $12.7 billion last year. HCA Healthcare is one of the largest for-profit hospital operators in the U.S. and its current analyst consensus rating is 17 buys, 7 holds and 0 sells, according to Bloomberg.
Looking at a daily chart, HCA Healthcare's stock price appears to have formed a intermediate-term symmetrical triangle pattern that began to form in the early months of 2020. On a more short-term basis the company has been advancing in an uptrend since late September. Price is currently being stopped at the upper trendline of the symmetrical triangle and in the last 5 days of trading most of the candle sticks have formed short real bodies with long wicks hinting at indecision. The RSI is showing divergence as price made a slightly higher high in October than it did in early September and the RSI made a lower high. Price will likely begin a new short-term downtrend and head for 114.00. Price will probably find support at 114.00 and chop around before reaching for 101.00. On the other hand, if price can manage to get over 140.00 then it could retest the record high of roughly 152.00. If price gets above 152.00, then it could continue to rise.
Source: GAIN Capital, TradingView
Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.
Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.